ID   TUHR3TKB
AC   CVCL_5956
SY   TUHR-3TKB
DR   CLO; CLO_0050895
DR   BioSample; SAMN03472175
DR   RCB; RCB1187
DR   Wikidata; Q54973373
RX   PubMed=9914789;
CC   Population: Japanese.
CC   HLA typing: A*02,24:02 (PubMed=9914789).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=9914789; DOI=10.1111/j.1349-7006.1998.tb00515.x;
RA   Liu S.-Q., Kawai K., Shiraiwa H., Hayashi H., Akaza H., Hashizaki K.,
RA   Shiba R., Saijo K., Ohno T.;
RT   "High rate of induction of human autologous cytotoxic T lymphocytes
RT   against renal carcinoma cells cultured with an interleukin
RT   cocktail.";
RL   Jpn. J. Cancer Res. 89:1195-1201(1998).
//